Abstract
The purpose of the study presented in this paper has been to examine the possibility of the synthesis of a new nanoparticulate system for controlled and systemic drug delivery with double effect. In the first step, a drug is released from bioresorbable polymer; in the second stage, after resorption of the polymer, non-bioresorbable calcium phosphate remains the chief part of the particle and takes the role of a filler, filling a bone defect. The obtained tigecycline-loaded calcium-phosphate(CP)/poly(dl-lactide-co-glycolide)(PLGA) nanoparticles contain calcium phosphate coated with bioresorbable polymer. The composite was analyzed by FT-IR, XRD and AFM methods. The average particle size of the nanocomposite ranges between 65 and 95 nm. Release profiles of tigecycline were obtained by UV–VIS spectroscopy in physiological solution at 37°C. Experimental results were analyzed using Peppas and Weibull mathematical models. Based on kinetic parameters, tigecycline release was defined as non-Fickian transport. The cytotoxicity of the nanocomposite was examined on standard cell lines of MC3T3-E1, in vitro. The obtained low values of lactate dehydrogenase (LDH) activity (under 37%) indicate low cytotoxicity level. The behaviour of the composite under real-life conditions was analyzed through implantation of the nanocomposite into living organisms, in vivo. The system with the lowest tigecycline content proved to be an adequate system for local and controlled release. Having in mind the registered antibiotics concentration in other tissues, delivery systems with a higher tigecycline content show both local and systemic effects.
Similar content being viewed by others
References
El-Kamel AH, Baddour MM. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation. Drug Deliv. 2007;14:349–56. doi:10.1080/10717540601098716.
Neut D, van de Belt H, Stokroos I, van Horn J, van der Mei H, Busscher H. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47:885–91. doi:10.1093/jac/47.6.885.
Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis. 2004;38:1049–55. doi:10.1086/382357.
Ratier A, Gibson I, Best S, Freche M, Lacout J, Rodrigez F. Setting characteristic and mechanical behaviour of a calcium phosphate bone cement containing tetracycline. Biomaterials. 2001;22:897–901. doi:10.1016/S0142-9612(00)00252-0.
Ratier A, Freche M, Lacout J, Rodrigez F. Behaviour of an injectable calcium phosphate cement with added tetracycline. Int J Pharm. 2004;274:261–8. doi:10.1016/j.ijpharm.2004.01.021.
Hylands J. Tigecycline: a new antibiotic. Intensive Crit Care Nurs. 2008;24:260–3. doi:10.1016/j.iccn.2008.03.006.
Harris R, Cruz M. Tigecycline (Tygacil): a novel first-in-class, broad-spectrum intravenous antibiotic for the treatment of serious bacterial infections. P & T. 2006;31:18–27.
El-Amin SF, Lu HH, Khan Y, Burems J, Mitchell J, Tuan RS, et al. Extracellular matrix production by human osteoblast cultured on biodegradable polymers applicable for tissue engineering. Biomaterials. 2003;24:1213–21. doi:10.1016/S0142-9612(02)00451-9.
Ignjatovic N, Ninkov P, Ajdukovic Z, Vasiljevic-Radovic D, Uskokovic D. Biphasic calcium phosphate/poly-dl-lactide-co-glycolide composite biomaterial as bone substitute. J Eur Ceram Soc. 2007;27:1589–94. doi:10.1016/j.jeurceramsoc.2006.04.104.
Ignjatovic N, Ajdukovic Z, Uskokovic D. New biocomposite calciumphosphate/poly-dl-lactide-co-glycolide/biostimulative agens filler for reconstruction of bone tissue changed by osteoporosis. J Mater Sci: Mater Med. 2005;16:621–6. doi:10.1007/s10856-005-2532-6.
Ajdukovic Z, Ignjatovic N, Petrovic D, Uskokovic D. Substitution of osteoporotic alveolar bone by biphasic calciumphosphate/poly-dl-lactide-co-glycolide biomaterials. J Biomater Appl. 2007;21:317–28.
Ignjatovic N, Ninkov P, Kojic V, Bokurov M, Srdic V, Krnojelac D, et al. Cytotoxicity and fibroblast properties during in vitro test of biphasic calcium phosphate/poly-dl-lactide-co-glycolide biocomposites and different phosphate materials. Microsc Res Tech. 2006;69:976–82. doi:10.1002/jemt.20374.
Pataro AL, Oliviera MF, Teixeira KI, Turchetti-Maia RM, Lopes MT, Wykrota FH, et al. Polymer: bioceramic composites optimization by tetracycline addition. Int J Pharm. 2007;336:75–81. doi:10.1016/j.ijpharm.2006.11.038.
Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolid acid) composite bone cement. Biomaterials. 2006;27:4239–49. doi:10.1016/j.biomaterials.2006.03.032.
Miyai T, Ito A, Tamazawa G, Matsuno T, Sogo Y, Nakamura C, et al. Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyalitis. Biomaterials. 2008;29:350–8. doi:10.1016/j.biomaterials.2007.09.040.
Xu Q, Czernuszka J. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactide-co-glycolic acid) microspheres. J Control Release. 2008;127:146–53.
Bohner M, Baroud G. Injectability of calcium phosphate pastes. Biomaterials. 2005;26:1553–63. doi:10.1016/j.biomaterials.2004.05.010.
Silva GA, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 1. Basic concepts. J Tissue Eng Regen Med. 2007;1:4–24. doi:10.1002/term.2.
Ritger P, Peppas N. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5:23–36. doi:10.1016/0168-3659(87)90034-4.
Weibull W. A statistical distribution functional of wide applicability. ASME Trans J Appl Mech. 1951;18:293–7.
Stevanovic M, Savic J, Jordovic B, Uskokovic D. Fabrication, in vitro degradation and the release behaviours of poly(dl-lactide-co-glycolide) nanospheres containing ascorbic acid. Colloids Surf B Biointerfaces. 2007;59:215–23. doi:10.1016/j.colsurfb.2007.05.011.
Ignjatovic N, Uskokovic D. Molecular spectroscopy analysis of the substitution of bone tissue by HAp/PLLA composite biomaterial. Spectros-Int J. 2004;18:553–65.
Costantino L, Gandolfi F, Bossy-Nobs L, Tosi G, Gurny R, Rivasi F, et al. Nanoparticulate drug carriers based on hybrid poly(d, l-lactide-co-glycolide)-dendron structures. Biomaterials. 2006;27:4635–45. doi:10.1016/j.biomaterials.2006.04.026.
JCPDS File No. 9-432, International Center for Diffraction Data.
Martinez-Sancho C, Herrero-Vanrell R, Negro S. Study of gamma-irradiation effects on aciclovir poly(d, l-lactic-co-glycolic) acid microspheres for intravitreal administration. J Control Release. 2004;99:41–52. doi:10.1016/j.jconrel.2004.06.004.
LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and application. J Mater Sci: Mater Med. 2003;14:201–9. doi:10.1023/A:1022872421333.
Kumta PN, Sfeir C, Lee DH, Olton D, Choi D. Nanostructured calcium phosphates for biomedical applications: novel synthesis and characterization. Acta Biomater. 2005;1:65–83. doi:10.1016/j.actbio.2004.09.008.
Suslick K. The yearbook of science and the future 1994, Encyclopedia Britanica, Chicago; 1994. p. 138–55.
Suslick KS. Sonochemistry. Science. 1990;247:1439–45. doi:10.1126/science.247.4949.1439.
Markovic S, Mitric M, Starcevic G, Uskokovic D. Ultrasonics de-agglomeration of barium titanate powder. Ultrason Sonochem. 2008;15:16–20. doi:10.1016/j.ultsonch.2007.07.008.
Ignjatovic N, Uskokovic D. Biodegradable composites based on nano-crystalline calcium phosphate and bioresorbable polymers. Adv Appl Ceram. 2008;107:142–7. doi:10.1179/174367608X263421.
Ignjatovic NL, Liu CZ, Czernuszka JT, Uskokovic DP. Micro and nano/injectable composite biomaterials of calcium phosphate coated with poly(dl-lactide-co-glycolide). Acta Biomater. 2007;3:927–35. doi:10.1016/j.actbio.2007.04.001.
Stevanovic M, Jordovic B, Uskokovic D. Preparation and characterization of poly(d, l-lactide-co-glycolide) nanoparticles containing ascorbic acid. J Biomed Biotechnol. 2007;2007:84965. doi:10.1155/2007/84965.
Siepmann J, Siepmann F. Mathematical modeling of drug release. Int J Pharm. 2008;364:328–43. doi:10.1016/j.ijpharm.2008.09.004.
Gbureck U, Vorndran E, Barrelet J. Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomater. 2008;4:1480–6. doi:10.1016/j.actbio.2008.02.027.
Jorgensen K, Jacobsen L. Factorial design used for ruggedness testing of flow through cell dissolution method by means of Weibull transformed drug release profiles. Int J Pharm. 1992;88:23–9. doi:10.1016/0378-5173(92)90300-Q.
Saettone M, Cheton P, Mariotti Bianch L, Giannaccin B, Conte U, Sangalli M. Controlled release of timolol maleate from coated ophthalmic mini-tablets prepared by compression. Int J Pharm. 1995;126:79–82. doi:10.1016/0378-5173(95)04096-X.
Hasimi A, Stavropoulou A, Papadokostaki K, Sanopoulou M. Transport of water in polyvinyl alcohol films: effect of thermal treatment and chemical crosslinking. Eur Polym J. 2008;44:4098–107. doi:10.1016/j.eurpolymj.2008.09.011.
Ahn JS, Choi HK, Chun MK, Ryu JM, Jung JH, Kim YU, et al. Release of triamcinolone acetonide from mucoadhesive polymer composed of chitosan and poly(acrylic acid) in vitro. Biomaterials. 2002;23:1411–6. doi:10.1016/S0142-9612(01)00261-7.
Edwards D. Non-Fickian transport. J Polym Sci B Polym Phys. 1996;34:981–97. doi:10.1002/(SICI)1099-0488(19960415)34:5<981:AID-POLB16>3.0.CO;2-7.
Bettany JT, Wolowacz RG. Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells. Adv Dent Res. 1998;12:136–43. doi:10.1177/08959374980120010901.
Polson A, Bouwsma O, McNamara T, Golub L. Enhancement of alveolar bone formation after tetracycline administration in squirrel monkeys. J Appl Res Clin Dent. 2005;2:32–42.
Lee DK, Kim Y, Parks KS, Jang JW, Kim K, Na NJ. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/alfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005). J Biochem Mol Biol. 2007;40:881–7.
Acknowledgements
This study was supported by the Ministry of Science and Technological Development of the Republic of Serbia, under Grant No. 142006: Synthesis of functional materials with controlled structure on molecular and nano- levels. The authors would like to thank to Dr. D. Vasiljevic-Radovic for AFM analysis, Dr. M. Mitric for his kind help help in X ray measurements and Dr. M. Dramicanin for DLS analysis. The study is a result of joint research carried out by the Department of Biomaterials, Faculty of Dentistry, University of Oslo, under the guidance of Prof. Dr. Petter Lyngstadaas and Institute of Technical Sciences of the Serbian Academy of Sciences and Arts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ignjatović, N.L., Ninkov, P., Sabetrasekh, R. et al. A novel nano drug delivery system based on tigecycline-loaded calciumphosphate coated with poly-dl-lactide-co-glycolide. J Mater Sci: Mater Med 21, 231–239 (2010). https://doi.org/10.1007/s10856-009-3854-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-009-3854-6